Ramy Riad Ahmed Ibrahim
CIK: 0002121395
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TAK
TAKEDA PHARMACEUTICAL CO LTD
Officer
Discretionary Trading P&L
Holdings
About Ibrahim Ramy Riad Ahmed
Ibrahim Ramy Riad Ahmed (SEC CIK 0002121395) files insider reports with the SEC as President, PDT BU of TAKEDA PHARMACEUTICAL CO LTD (TAK).
Signal8 holds 3 ownership filings by Ibrahim Ramy Riad Ahmed (1 Form 3, 2 Form 4), filed between Apr 6, 2026 and Aug 12, 2026. Those filings report 2 transactions, from Jul 1, 2026 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ibrahim Ramy Riad Ahmed's filings is in CAMBRIDGE, MA.
Recent filings by Ibrahim Ramy Riad Ahmed
Other insiders filing for TAKEDA PHARMACEUTICAL CO LTD (TAK)
- Duprey Lauren Rusckowski, Chief Transformation Officer
- Plump Andrew Stewart, President, R&D
- Greenway Nicola Deidre Petal, Chief Human Resources Officer
- Farajallah Awny Samaan Botros, Chief Medical Officer
- Pacheco Rhonda Janice, President, U.S. Business Unit
- Pignagnoli Agosti Marcello, Head, Strat. & Port. Dev